Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)
Sreya Duttagupta, Meriem Messaoudene, Rahima Jamal, Catalin Mihalcioiu, Nicolas Marcoux, Sebastian Hunter, Gianmarco Piccinno, Michal Punčochář, Karl Bélanger, Mustapha Tehfé, Normand Blais, Scott Owen, Jacques Raphael, Jade Maillou, Yongjia Hu, Myriam Benlaïfaoui, Somayeh Nilli, John Lenehan, Wiam Belkaïd, Seema Nair Parvathy, Diogjena Katerina Prifti, Marine Fidelle, Seunghee Kim‐Schulze, Thomas U. Marron, Sylvère Durand, Guido Guido Kroemer, Nicola Segata, Lisa Derosa, Laurence Zitvogel, Antoine Desîlets, Michael E. Silverman, Saman MalekiVareki, Bertrand Routy, Arielle Elkrief (2025). Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583). , 85(8_Supplement_1), DOI: https://doi.org/10.1158/1538-7445.am2025-2210.
